Fig. 3From: Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survivalAnalysis after propensity score-based overlap weighting A Cumulative survival according to etoposide status (Kaplan–Meier estimates, log-rank’s test). B Cumulative incidence function (CIF) of HAIs according to etoposide status (Gray’s test)Back to article page